Private equity house PAI Partners put negotiations to buy 100% of Spain's largest care group SARquavitae on hold in late July. Sources told Healthcare Europa that the price has already been set at €500-550m, roughly 15x EBITDA. But there are discrepancies on how to formalise the agreement. We're still waiting for official talks to resume after the summer, which otherwise could close this very month.